NVTA.Q logo

Invitae Corporation Stock Price

OTCPK:NVTA.Q Community·US$114.6k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NVTA.Q Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

NVTA.Q Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low and slightly overvalued.

6 Risks
0 Rewards

Invitae Corporation Key Details

US$481.6m

Revenue

US$350.9m

Cost of Revenue

US$130.6m

Gross Profit

US$1.6b

Other Expenses

-US$1.4b

Earnings

Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
n/a
-5.03
27.13%
-299.14%
-124.7%
View Full Analysis

About NVTA.Q

Founded
2010
Employees
1700
CEO
Kenneth Knight
WebsiteView website
www.invitae.com

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.

Recent NVTA.Q News & Updates

Recent updates

No updates